FDA Investigator Darren S Brown

Darren S Brown has inspections in 14 countries as of 18 Oct 2023. Darren S Brown has collaborated with a combinined 5259 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
91
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100007305
Country:
United States of America, Italy, India, France, China, Denmark, Sweden, United Kingdom of Great Britain and Northern Ireland, Japan, Spain, Switzerland, Australia, Norway, Poland
Co-Investigator(s):
Ademola O Daramola, Alan L Truong, Alan P Kurtzberg, Alexandra B Pitkin, Alicia M Mozzachio, Amanda L Fyles, Anderson, Andrea A Branche, Andrew K Haack, PhD, Andrew Le, Andy B Lee, Angela Shepas, Anita Narula, PhD, Anthony A Charity, April L Young, Armando Chavez, MS, Arsen Karapetyan, Ashar P Parikh, Babajide Michael Osunsanmi, Babatunde D Babalola, Bapu R Gaddam, Barbara J Rincon, Barbara Janine Breithaupt, Bernice F Hirsch, Bernice Hirsh, Bichsa T Tran, Binh T Nguyen, Bonita S Chester, Bowman, Bryan A Galvez, Bryce A Hammer, Burnsb, Carl A Huffman, III, Carl Lee, Carla J Lundi, Carolina D Vasquez, Carr Sharpe, Caryn M Mcnab, Celena Ngo, Charles M Edwards, Charles R Cote, RIC, Chong Ming Cheng, Chorng M Cheng, Christopher D Washington, Christopher M Hernandez, Christopher M Jenner, Christopher T Middendorf, Constantin Y Philopoulos, Crystal Monroy, Dale A Nyberg, Dandan Wang, PhD, Daniel J Roberts, David M Beltran, Deborah A Greco, Deborah W Hsu, Debra I Love, Demitria J Xiradakis, Desiree C Iya, Diana M Rand, Diane Cvan Leeuwen, Diane R Weidley, Djamila Harouaka, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Donald L Lech, Dongping Dai, PhD, Douglas C Kovacs, Dr. Carmelo Rosa, Dr. Gang Wang, PhD, Dyana K Stone, Eileen A Liu, Eileen T Dupont, Elizabeth B Griffin, Ellen N Stewart, Emily J Orban, Emmanuel J Ramos, Eric M Mueller, PharmD, Erik W Koester, Esther B Gamallo Herrera, Evelyn Wong, Farhana Khan, Felix Maldonado, Finn A Slizza, Francisco, Freddy Ortiz Colon, Frederick Razzaghi, Gabriel Craig, Garciam, Gavin T Cua, Gene D Arcy, Greg K Keshishyan, Harry J Brewer, Heidy C Perales, Henry E Carrillo, Herminio C Francisco, Hinh T Nguyen, Hoover, Hung H Do, MS, Isabel Y Espinosa, Jai P Singh, James A Barreto, James L Dunnie, Jr, James Norman, James P Stallings, James R Fleckenstein, Jane L Chang, Jasmine N Thompson, Javier O Vega, Jeff M Uriarte, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer L Gustavus, Jennifer L Huntington, Jennifer M Gogley, Jinnie Kokiatkulkij, Jocelyn E Massey, Joel D Hustedt, Joey V Quitania, Jog George, Jogy George, John A Gonzalez, John L Stevens, John P Jorgensen, Jolanna A Norton, Jonathan K Dare, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose R Hernandez, Juanita Banuelos, Juanita P Versace, Jude C Dikes, Judy C Nepsa, Junho Pak, Justin A Boyd, Karthikeyan Kanakarajan (NMI), Karyn M Campbell, Katherine E Jacobitz, Katherine Szestypalow, Kathy Kuo, Kawshalya Pathiraja, Keith P Iams, Kejun Cheng, Kelley, Kellia N Hicks, Kelvin X Sanders, Kenneth O Gee, PhD, Kent C Faul, Kevin D Kallander, Kevin N Tran, Kham Phommachanh, Khanh T Van, Khoa Nathanv Tran, Kim Lthomas Cruse, Kirtida Patel, Kristin M Abaonza, Lakecha N Lewis, Lance M De Souza, MBA, Langer, Lanita F Kelley, Larry K Austin, Laurie B Frazier, Laurie Nelson, LCDR Chad N Thompson, Lilly O Barton, Liming Zhang, Linda L Ng, Linda Thai, Lisa M Bellows, Lisa Shin, Louis B Cencetti, Lucila B Nwatu, Lynette M Terry, M Jasnethoson Thompson, Maida Henesian (NMI), Marcellinus D Dordunoo, Marcus F Yambot, Marie F Morin, Marijo B Kambere, PhD, Mariza M Jafary, Mark C Saale, Mark E Chan, Marvin D Jones, Matthew B Casale, Maya M Davis, Meisha R Sampson, Meisha Waters, Michael A Charles, Michael D Garcia, Michael E Maselli, Michael P Sheehan, Michael R Goga, Michael R Klapal, Michael T Cyrus, Michele Perry Williams, Miguel A Martinez, Minh D Phan, Monica M Mcclure, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nancy E Byerly, Naveen B Walker, Nayan J Patel, Nianna C Burns, Nicholas L Hunt, Nicholas L Paulin, Pal S Mayasandra, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patricia H Dlugosz, Paul A Bonneau, Phal K Chhun, Phillip L Toy, Pratik S Upadhyay, DDC, Rachael O Oyewole, Rajiv R Srivastava, Ralph H Vocque, Randall N Johnson, Richard H Penta, Richard W Tubb, Richmond K Yip, Robert C Hoover, Robert D Tollefsen, Robert J Doyle, Robert J Martin, Rochelle A Rolnik, Roger F Zabinski, Rose Ljean Mary, Rose Xu, Rowena S Nguyen, Roy R Rinc, Rumany C Penn, PharmD, Saied A Asbagh, Saleem A Akhtar, Sandersk, Sandra A Hughes, Sangeeta M Khurana, PhD, Sanket N Patel, Santiago Gallardo Johnson, Santos E Camara, Satheesh Thomas, Scott T Ballard, Sean P Desbrow, Selene T Torres, Shirley J Berryman, Sidonie J Takougang, Simone E Pitts, Sixto M Mercado Rios, Sonya L Karsik, State Agency, Stephanie A Slater, MS, Stephen D Brown, Steven E Porter, Jr, Steven P Donald, Sue Lee Chan, Sundy Ven, Susanna E Ford, Analyst, Susant Hadman, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Tamil Arasu, PhD, Tawny L Colling, Teresa T Cain, Terrance L Thomas, Thao T Kwan, Theresa Kirkham (NMI), Thomas E Friel, Tianhong Zhou, Timothy T Kapsala, Tonia F Bernard, Toyin B Oladimeji, Tracey L Harris, Tracey T Duong, Tracy K Li, Tricia S Martinez, Truong Xuan Nguyen (Andy), Ucheabuchi C Chudi Nwankwor, Uttaniti Limchumroon (Tom), Vasant G Malshet, PhD, Vashti E Bocker, Vibhakar J Shah, PhD, Vickie L Anderson, Virgilio F Pacio, CSO, Walden H Lee, William J Leonard, William V Millar, Xiaohui Shen, Xiaokuang Lai, PhD, Xiaoping Guan, Yasamin Ameri, Yong Hu, Yumi J Hiramine, Yvette E Guillermo, Yvette Mlacour Davis, Yvins Dezan, Zachary A Bogorad, Zachary L Miller, Zi Qiang Gu

Darren S Brown's Documents

Publish Date Document Type Title
May, 2022 FDA 483 Aurobindo Pharma Limited - Form 483, 2022-05-10
August, 2021 FDA 483 Optum Compounding Services, LLC - Form 483, 2021-08-13
December, 2017 EIR QPharma AB - EIR, 2017-12-15
September, 2016 FDA 483 Island Kinetics, Inc. d.b.a. CoValence Laboratories - Form 483, 2016-09-02
April, 2019 FDA 483 Laboratorio Reig Jofre Sa. - Form 483, 2019-04-05
April, 2017 FDA 483 California Pharmacy & Compounding Center - Form 483, 2017-04-21
May, 2017 FDA 483 Strides Pharma Science Limited - Form 483, 2017-05-26
October, 2016 FDA 483 New Era Pharmacy, LLC - Form 483, 2016-10-04
December, 2018 FDA 483 MYLAN LABORATORIES LIMITED - Form 483, 2018-12-10
September, 2021 FDA 483 STAQ Pharma, Inc. - Form 483, 2021-09-29
September, 2015 FDA 483 Chen Shwezin, Inc. dba Park Compounding Pharmacy - Form 483, 2015-09-11
August, 2015 FDA 483 Cosmedx Science Inc. - Form 483, 2015-08-26
November, 2015 FDA 483 Auro Pharmacies, Inc. - Form 483, 2015-11-05
September, 2018 FDA 483 Flamma SpA - Form 483, 2018-09-21
March, 2016 FDA 483 ImprimisRx CA, Inc., dba ImprimisRx - Form 483, 2016-03-14
May, 2022 FDA 483 Aurobindo Pharma Limited - Form 483, 2022-05-10
February, 2020 EIR Granules India Limited - EIR, 2020-02-14
June, 2016 FDA 483 CUSTOM RESEARCH LABS INC - Form 483, 2016-06-01
November, 2021 EIR GURUNANDA LLC - EIR, 2021-12-09
May, 2018 FDA 483 ZAKLADY FARMACEUTYCZNE POLPHARMA S A - Form 483, 2018-05-25
May, 2017 EIR Strides Pharma Science Limited - EIR, 2017-05-26
April, 2018 FDA 483 Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (FDF Site) - Form 483, 2018-04-03
November, 2015 FDA 483 Discus Dental, LLC - Form 483, 2015-11-23
November, 2019 FDA 483 Fuji Yakuhin Co., Ltd. - Form 483, 2019-11-26
August, 2022 FDA 483 Clean Cosmetics, LLC - Form 483, 2022-08-19
June, 2016 FDA 483 P & L Development, LLC - Form 483, 2016-06-24
December, 2017 FDA 483 QPharma AB - Form 483, 2017-12-15
May, 2017 FDA 483 LUPIN LIMITED - Form 483, 2017-05-19
August, 2023 FDA 483 Logix Biosciences Inc. - Form 483, 2023-09-06
November, 2018 FDA 483 Gordon Laboratories - Form 483, 2018-11-19
July, 2022 FDA 483 VMP Cosmetics, LLC - Form 483, 2022-07-13
September, 2021 FDA 483 Response STAQ Pharma, Inc. - Form 483R, 2021-10-18
March, 2023 FDA 483 Palisades Compounding Pharmacy - Form 483, 2023-03-15
December, 2018 EIR Analys Lab Private Limited - EIR, 2018-12-21
August, 2019 FDA 483 Calmo Manufacturing Inc - Form 483, 2019-08-23
October, 2019 FDA 483 MICRO CONNECTION ENTERPRISES, INC., THE - Form 483, 2019-10-30
May, 2018 FDA 483 Pharmacosmos A/S - Form 483, 2018-05-18
March, 2018 FDA 483 TECHNICHEM CORP - Form 483, 2018-03-09
December, 2016 EIR Vita-Herb Nutriceuticals - EIR, 2016-12-12
December, 2016 FDA 483 Vita-Herb Nutriceuticals - Form 483, 2016-12-12
March, 2022 FDA 483 West Coast Cosmetics, Inc. - Form 483, 2022-03-09
July, 2015 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2015-07-17
September, 2021 EIR STAQ Pharma, Inc. - EIR, 2021-10-26
November, 2015 FDA 483 Response Auro Pharmacies, Inc. - Form 483R, 2015-11-20
July, 2017 FDA 483 Instituto Biochimico Italiano Giovanni Lorenzini SpA - Form 483, 2017-07-04
March, 2016 FDA 483 Element Materials Technology Pharma US LLC - Form 483, 2016-03-25
June, 2019 FDA 483 Laboratorio Reig Jofre Sa. - Form 483, 2019-06-14
February, 2020 FDA 483 Kreative Organics Private Limited - Form 483, 2020-02-07
April, 2019 FDA 483 Cyndea Pharma SL - Form 483, 2019-04-12
September, 2023 FDA 483 Orange Lab - Form 483, 2023-10-25
July, 2023 FDA 483 Product Packaging West, Inc. - Form 483, 2023-07-18
October, 2023 FDA 483 Morgan Gallacher - Form 483, 2023-10-26
December, 2023 FDA 483 Blaine Labs Inc. - Form 483, 2023-12-15

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more